en · de · es · fr · pt
aod-9604-notes.peptides5388.com › News › Research And Regulatory Status — Explained

Research And Regulatory Status — Explained

By Editorial Desk · published 2026-01-30 · last reviewed 2026-02-16 · News

A practical reference on AOD-9604: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.

This page was last updated on 2026-02-16 and is reviewed periodically as new material appears.

Research and Regulatory Status

AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.

Regulatory treatment of AOD-9604 has varied. In sports anti-doping, the peptide became widely discussed during a 2013 investigation into an Australian professional sports club. Authorities at the time debated whether it fell under prohibitions on growth hormone and related substances. Later clarifications and updated lists have addressed the compound in different ways. Anyone seeking current status should consult the latest applicable rules, and commercial supply for human use is not authorized in major markets.

Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.

Background and Molecular Identity

AOD-9604 is a synthetic peptide whose structure corresponds to a C-terminal segment of human growth hormone. It is often described as hGH fragment 176-191, a 16-amino-acid sequence. The peptide was designed to isolate a region of hGH associated with fat metabolism while avoiding the full hormone's growth-promoting actions. Laboratory and commercial materials typically present it as a lyophilized powder for research use. Its identity is defined by amino acid sequence, not by a single brand.

The fragment includes residues that can form an internal disulfide bond between two cysteine positions. This structural feature can influence how the peptide folds and how stable it is in solution. AOD-9604 differs from full-length hGH in size and receptor interactions; it does not contain the entire growth hormone sequence. Published descriptions sometimes use slightly different residue numbering, so sequence information should be checked against primary sources. The molecule is small compared with intact hGH, which affects analytical detection and purification approaches.

Interest in AOD-9604 arose from attempts to separate metabolic effects from growth effects attributed to hGH. Early work explored whether the fragment could influence lipolysis or fat oxidation without promoting growth. Those questions remain partly unresolved because human data are limited and results have varied across studies. The peptide is not a hormone replacement for hGH and is not equivalent to hGH in clinical use. Its research history includes both laboratory studies and commercial marketing claims that are not the same as regulatory approval.

Aod-9604 at a glance

PropertyValueNotes
Primary research areaObesity and metabolic regulationStudied in cell, animal, and human models
Highest reported trial phasePhase IIPublic summaries describe mixed results
Common route in trialsSubcutaneous injectionTypical for peptide therapeutics
Regulatory example2013 Australian anti-doping reviewClassification was debated at the time
Approval statusNot approved as a human medicineStatus can change by jurisdiction

Notes from published material

In continuum mechanics, the generalized Lagrangian mean (GLM) is a formalism – developed by D.G. Andrews and M.E. McIntyre (1978a, 1978b) – to unambiguously split a motion into a mean part and an oscillatory part. The method gives a mixed Eulerian–Lagrangian description for the flow field, but appointed to fixed Eulerian coordinates.

Reynolds was powerless to prevent the inevitable; although leading at half-time, Geelong kicked five goals to Essendon's two points in the third quarter to set up victory by 11 points. Essendon slumped to 8th in 1952, but Coleman was in strong form, managing 103 goals for the year. Two seasons later, Coleman's career was ended after he dislocated a knee during the Round 8 clash with the North Melbourne Football Club at Essendon. Aged just 25, he had kicked 537 goals in only 98 VFL games. Following Coleman's career-ending knee injury, Essendon won no further premierships in the 1950s. In 1957, Essendon defeated Melbourne by 16 points in the Second Semi-Final, but lost the grand final to Melbourne by 61 points. The 1959 season ended with a 37-point grand final loss to Melbourne. Essendon would win their next premiership three years later in 1962.

Penalties for drug crimes among American youth almost always involve permanent or semi-permanent removal from opportunities for education, strip them of voting rights, and later involve creation of criminal records which make employment more difficult. One-fifth of the US prison population are incarcerated for a drug offense. Thus, some authors maintain that the war on drugs has resulted in the creation of a permanent underclass of people who have few educational or job opportunities, often as a result of being punished for drug offenses which in turn have resulted from attempts to earn a living in spite of having no education or job opportunities. In her 2010 book, The New Jim Crow: Mass Incarceration in the Age of Colorblindness, Michelle Alexander argues that the war on drugs has effectively perpetuated a racial caste system, with African American and Hispanic individuals experiencing disproportionately high rates of arrest, conviction, and incarceration for drug-related offenses. This system functions as a modern form of racial control, stripping individuals of their rights and opportunities, and reinforcing societal inequalities. According to Alexander, the consequences extend beyond criminal justice, affecting economic opportunities, access to education, and overall social mobility for affected individuals and communities.

Sources: en.wikipedia.org

Related pages on this site

Background from the literature

== Fabrication == Graphene aerogels are synthetic materials that exhibit high porosity and low density. Typical syntheses of graphene aerogels involve reducing a precursor graphene oxide solution to form graphene hydrogel. The solvent can be subsequently removed from the pores by freeze-drying and replacing with air. The resulting structure consists of a network of covalently bonded graphene sheets surrounding large pockets of air, resulting in densities on the order of 3 mg cm−3. Graphene aerogel morphologies have also been demonstrated to be controllable through 3D printing methods. Graphene oxide ink composed of graphene oxide gelled in a viscous solution with the addition of silica to lower viscosity and enable printability of the graphene oxide ink. The ink is then extruded from a nozzle into isooctane, which prevents the ink from drying too quickly. Subsequently, the solvent can be removed by freeze drying, while the silica can be removed with a hydrofluoric acid solution. The resulting 3D lattice can be highly ordered while maintaining the high surface areas and low densities characteristic of graphene aerogels.

While South Africa is known to be one of the more LGBTQ-friendly nations in the southern parts of Africa, corrective rape is still reported in South Africa. Rape, including corrective rape, disproportionately affects Black women. In South Africa, women are often seen as having less sexual and economic power than men. One of the factors associated with this inequality is strict gender roles, which have led to one of the highest rates of violence against women in the world. The South African government conducted a survey in 2009 on sexual assault. One in four men admitted to engaging in sexual activity with a woman who did not consent and nearly half of those men admitted to raping more than once. It is also estimated that a woman is raped every 26 seconds in South Africa. Corrective rape is used as a punishment for people who are gay or do not fit traditional gender roles, where often they are verbally abused before the rape. The perpetrator may claim to be teaching the women a lesson on how to be a "real woman". Because women have less control over their economic situation, which creates economic vulnerability, they have less control over their own sexual activities. Poor Black women who live in townships are more likely to become victims of corrective violence, and gay women are more likely to be isolated with little support, which increases their chances of being targeted. The South African Constitution states that no person shall be discriminated against based on their gender, race, or sexual orientation.

Some gas panels have a separate supply gauge for each diver downstream of the supply valve, but this is not standard practice. The gas panel may be fairly large and mounted on a board for convenience of use, or may be compact and mounted inside a portable box, for ease of transport. Gas panels are usually for one, two or three divers. In some countries, or under some codes of practice, the surface standby diver must be supplied from a separate panel to the working diver/s. A wet or closed bell will be fitted with a bell gas panel to supply gas to the divers' excursion umbilicals. The bell gas panel is supplied with primary gas from the surface via a bell umbilical, and on-board emergency gas from high-pressure storage cylinders mounted on the frame of the bell.

Sources: en.wikipedia.org

Frequently asked questions

Has AOD-9604 been approved as a medicine?

No major medicines regulator appears to have approved AOD-9604 for human therapeutic use. It has been studied in clinical trials, but those programs did not result in a marketed drug.

Why is AOD-9604 discussed in anti-doping?

It became prominent during a 2013 Australian sports investigation that examined whether it was a prohibited growth-hormone-related substance. Subsequent interpretations and list updates have varied, so current rules should be checked directly.

What did human trials of AOD-9604 find?

Published summaries generally report limited or inconsistent weight-loss effects, and complete trial data are not widely available. The studies were not sufficient to establish it as an effective obesity treatment.

What is AOD-9604?

It is a synthetic peptide based on a C-terminal fragment of human growth hormone. It is commonly referred to as hGH fragment 176-191 and is studied for metabolic effects rather than growth effects.

Network